U.S. Physical Therapy, Inc. (USPH) Shares Bought by Citadel Advisors LLC

Citadel Advisors LLC grew its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 22.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 9,147 shares of the company’s stock after buying an additional 1,689 shares during the period. Citadel Advisors LLC owned approximately 0.07% of U.S. Physical Therapy worth $552,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Invictus RG acquired a new position in U.S. Physical Therapy in the 1st quarter worth $100,000. Pinebridge Investments L.P. boosted its stake in U.S. Physical Therapy by 1.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after purchasing an additional 17 shares during the period. Sei Investments Co. boosted its stake in U.S. Physical Therapy by 9.0% in the 1st quarter. Sei Investments Co. now owns 1,954 shares of the company’s stock worth $128,000 after purchasing an additional 162 shares during the period. State of Alaska Department of Revenue boosted its stake in U.S. Physical Therapy by 77.8% in the 2nd quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after purchasing an additional 1,074 shares during the period. Finally, Municipal Employees Retirement System of Michigan boosted its stake in U.S. Physical Therapy by 3.1% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after purchasing an additional 90 shares during the period. 94.94% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy, Inc. (USPH) Shares Bought by Citadel Advisors LLC” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://ledgergazette.com/2017/10/09/u-s-physical-therapy-inc-usph-shares-bought-by-citadel-advisors-llc.html.

Shares of U.S. Physical Therapy, Inc. (USPH) opened at 63.50 on Monday. The firm’s 50-day moving average is $59.80 and its 200 day moving average is $62.56. U.S. Physical Therapy, Inc. has a 12 month low of $51.96 and a 12 month high of $78.00. The company has a market capitalization of $798.89 million, a PE ratio of 40.19 and a beta of 1.06.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.01). The company had revenue of $104.25 million during the quarter, compared to analyst estimates of $102.93 million. U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. Equities research analysts predict that U.S. Physical Therapy, Inc. will post $2.12 EPS for the current year.

A number of equities analysts recently weighed in on USPH shares. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 target price for the company in a research note on Monday, July 3rd. Jefferies Group LLC reaffirmed a “hold” rating and issued a $63.00 target price on shares of U.S. Physical Therapy in a research note on Friday, June 30th. Zacks Investment Research lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Saturday, August 26th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $72.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, September 26th. Finally, Sidoti raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their target price for the stock from $62.00 to $74.00 in a research note on Friday, September 8th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $68.60.

In other news, CFO Lawrance W. Mcafee sold 3,000 shares of U.S. Physical Therapy stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $62.04, for a total transaction of $186,120.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Glenn Mcdowell sold 1,664 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, August

Several other hedge funds have also recently made changes to their positions in the company. Invictus RG acquired a new position in U.S. Physical Therapy in the 1st quarter worth $100,000. Pinebridge Investments L.P. boosted its stake in U.S. Physical Therapy by 1.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after purchasing an additional 17 shares during the period. Sei Investments Co. boosted its stake in U.S. Physical Therapy by 9.0% in the 1st quarter. Sei Investments Co. now owns 1,954 shares of the company’s stock worth $128,000 after purchasing an additional 162 shares during the period. State of Alaska Department of Revenue boosted its stake in U.S. Physical Therapy by 77.8% in the 2nd quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after purchasing an additional 1,074 shares during the period. Finally, Municipal Employees Retirement System of Michigan boosted its stake in U.S. Physical Therapy by 3.1% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after purchasing an additional 90 shares during the period. 94.94% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy, Inc. (USPH) Shares Bought by Citadel Advisors LLC” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://ledgergazette.com/2017/10/09/u-s-physical-therapy-inc-usph-shares-bought-by-citadel-advisors-llc.html.

Shares of U.S. Physical Therapy, Inc. (USPH) opened at 63.50 on Monday. The firm’s 50-day moving average is $59.80 and its 200 day moving average is $62.56. U.S. Physical Therapy, Inc. has a 12 month low of $51.96 and a 12 month high of $78.00. The company has a market capitalization of $798.89 million, a PE ratio of 40.19 and a beta of 1.06.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.01). The company had revenue of $104.25 million during the quarter, compared to analyst estimates of $102.93 million. U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. Equities research analysts predict that U.S. Physical Therapy, Inc. will post $2.12 EPS for the current year.

A number of equities analysts recently weighed in on USPH shares. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 target price for the company in a research note on Monday, July 3rd. Jefferies Group LLC reaffirmed a “hold” rating and issued a $63.00 target price on shares of U.S. Physical Therapy in a research note on Friday, June 30th. Zacks Investment Research lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Saturday, August 26th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $72.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, September 26th. Finally, Sidoti raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their target price for the stock from $62.00 to $74.00 in a research note on Friday, September 8th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $68.60.

In other news, CFO Lawrance W. Mcafee sold 3,000 shares of U.S. Physical Therapy stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $62.04, for a total transaction of $186,120.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Glenn Mcdowell sold 1,664 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $59.91, for a total transaction of $99,690.24. The disclosure for this sale can be found here. Insiders have sold 13,266 shares of company stock valued at $801,134 over the last quarter. Corporate insiders own 3.10% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply